These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39190577)

  • 1. Symmetric Dimethylarginine Predicts Previously Undetected Atrial Fibrillation in Patients With Ischemic Stroke.
    Hannemann J; Wasser K; Mileva Y; Kleinsang F; Schubert M; Schwedhelm E; Guan K; Wachter R; Böger R
    J Am Heart Assoc; 2024 Sep; 13(17):e034994. PubMed ID: 39190577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
    Horowitz JD; De Caterina R; Heresztyn T; Alexander JH; Andersson U; Lopes RD; Steg PG; Hylek EM; Mohan P; Hanna M; Jansky P; Granger CB; Wallentin L;
    J Am Coll Cardiol; 2018 Aug; 72(7):721-733. PubMed ID: 30092948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Dimethylarginine Levels and Carotid Intima-Media Thickness are related to Atrial Fibrillation in Patients with Embolic Stroke.
    Grosse GM; Biber S; Sieweke JT; Martens-Lobenhoffer J; Gabriel MM; Putzer AS; Hasse I; van Gemmeren T; Schuppner R; Worthmann H; Lichtinghagen R; Bode-Böger SM; Bavendiek U; Weissenborn K
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine derivatives in atrial fibrillation progression phenotypes.
    Büttner P; Bahls M; Böger RH; Hindricks G; Thiele H; Schwedhelm E; Kornej J
    J Mol Med (Berl); 2020 Jul; 98(7):999-1008. PubMed ID: 32504111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADMA, subclinical changes and atrial fibrillation in the general population.
    Ramuschkat M; Appelbaum S; Atzler D; Zeller T; Bauer C; Ojeda FM; Sinning CR; Hoffmann B; Lackner KJ; Böger RH; Wild PS; Münzel T; Blankenberg S; Schwedhelm E; Schnabel RB;
    Int J Cardiol; 2016 Jan; 203():640-6. PubMed ID: 26580348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-arginine pathway metabolites can discriminate paroxysmal from permanent atrial fibrillation in acute ischemic stroke.
    Csecsei P; Várnai R; Nagy L; Kéki S; Molnár T; Illés Z; Farkas N; Szapáry L
    Ideggyogy Sz; 2019 Mar; 72(3-4):79-88. PubMed ID: 30957461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective study.
    Bima C; Parasiliti-Caprino M; Rumbolo F; Ponzetto F; Gesmundo I; Nonnato A; Fornengo P; Vaula G; Ghigo E; Mengozzi G; Settanni F
    Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1639-1648. PubMed ID: 38570234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
    Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
    Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome.
    Molnar T; Pusch G; Papp V; Feher G; Szapary L; Biri B; Nagy L; Keki S; Illes Z
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2206-2214. PubMed ID: 25018114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of endothelial pathology to support detection of atrial fibrillation in embolic stroke of undetermined source.
    Ziegler NL; Sieweke JT; Biber S; Gabriel MM; Schuppner R; Worthmann H; Martens-Lobenhoffer J; Lichtinghagen R; Bode-Böger SM; Bavendiek U; Weissenborn K; Grosse GM
    Sci Rep; 2019 Dec; 9(1):19424. PubMed ID: 31857660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke.
    Worthmann H; Chen S; Martens-Lobenhoffer J; Li N; Deb M; Tryc AB; Goldbecker A; Dong Q; Kielstein JT; Bode-Böger SM; Weissenborn K
    J Atheroscler Thromb; 2011; 18(9):753-61. PubMed ID: 21566344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease.
    Djordjević BV; Pavlović R; Ćosić V; Deljanin-Ilić M; Ristić T; Krstić N; Jevtović-Stoimenov T
    Amino Acids; 2012 Dec; 43(6):2293-300. PubMed ID: 22555650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation.
    Schnabel RB; Maas R; Wang N; Yin X; Larson MG; Levy D; Ellinor PT; Lubitz SA; McManus DD; Magnani JW; Atzler D; Böger RH; Schwedhelm E; Vasan RS; Benjamin EJ
    Am Heart J; 2016 Jun; 176():100-6. PubMed ID: 27264226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.
    Winkler MS; Nierhaus A; Rösler G; Lezius S; Harlandt O; Schwedhelm E; Böger RH; Kluge S
    Crit Care; 2018 Sep; 22(1):216. PubMed ID: 30231905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry.
    Martens-Lobenhoffer J; Bode-Böger SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 904():140-3. PubMed ID: 22884474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
    Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
    COPD; 2016; 13(2):139-45. PubMed ID: 26514682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.